<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03488199</url>
  </required_header>
  <id_info>
    <org_study_id>NRICP 9872</org_study_id>
    <nct_id>NCT03488199</nct_id>
  </id_info>
  <brief_title>The SIBERIA Trial (Acculink™ Versus CGuard™)</brief_title>
  <acronym>CAS</acronym>
  <official_title>Independent Randomized Trial in Carotid Artery Revascularization Comparing the Stent (Acculink™) Versus the Mesh Covered Stent (CGuard™) The SIBERIA Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meshalkin Research Institute of Pathology of Circulation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meshalkin Research Institute of Pathology of Circulation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      That the study will be carried out as it has the protocol instructions, respecting the
      applicable regulations for clinical investigations with medical devices and following the
      internationally accepted ethical standards
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Independent Randomized Trial in Carotid Artery Revascularization Comparing the Stent
      (Acculink™) Versus the Mesh Covered Stent (CGuard™) was performed.

      Ischemic lesions of brain after CAS were determined by MRI before and after treatment (2-3
      days, 1 month).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 11, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>determination of ischemic lesions</measure>
    <time_frame>at 30-days</time_frame>
    <description>New DW-MRI lesions post procedural their permanence at 30-days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>determination of ischemic lesions</measure>
    <time_frame>at 48 hours</time_frame>
    <description>New DW-MRI lesions post procedural (48 hours)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Patients With Aterosclerotic Carotid Stenosis</condition>
  <condition>Symptomatic Patients (Stenosis &gt; 50%)</condition>
  <condition>Asymptomatic Patients (Stenosis ≥80%)</condition>
  <arm_group>
    <arm_group_label>Stent Acculink™ (RX ACCULINK CAROTID STENT SYSTEM)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>50 Carotid stenting (RX ACCULINK CAROTID STENT SYSTEM)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stent CGuard™ (The CGuardTM Embolic Prevention System (EPS))</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50 Carotid stenting (The CGuardTM Embolic Prevention System (EPS))</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stent Acculink ™</intervention_name>
    <description>Carotid Artery Revascularization using Stents</description>
    <arm_group_label>Stent Acculink™ (RX ACCULINK CAROTID STENT SYSTEM)</arm_group_label>
    <other_name>RX ACCULINK CAROTID STENT SYSTEM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CGuardTM™</intervention_name>
    <description>Carotid Artery Revascularization using Stents</description>
    <arm_group_label>Stent CGuard™ (The CGuardTM Embolic Prevention System (EPS))</arm_group_label>
    <other_name>The CGuardTM Embolic Prevention System (EPS)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          1. Consecutive patients 45-80 years old accepted for CAS following neurological
             consultation and qualification for the procedure according to center's routine
             practice.

          2. More than 6-month life expectancy

          3. Suitable clinical conditions for performing DW-MRI

          4. Written Informed consent approved by the Ethics Committee

          5. Subject agrees to all required follow-up procedures and visits

        Exclusion Criteria:

          1. Currently enrolled in another investigational device or drug study that has not
             completed the study or that clinically interferes with the current study endpoints

          2. Recent surgical procedure within 30-days before or planned surgery within 30-days
             after the stenting procedure

          3. Hepatic active disease (bilirubin&gt; 35 mmol / l) or renal insufficiency (serum
             creatinine &gt; 2.5 mg/dL or glomerular filtration rate &lt;60 ml / min)

          4. Recent evolving acute stroke within 30-days of study evaluation

          5. Myocardial infarction within 72 hours prior to carotid stenting procedure (CPK-MB &gt; 3
             times normal)

          6. Female patients of childbearing potential or known to be pregnant

          7. Any known factor for potential stroke other than carotid stenosis, such as atrial
             fibrillation or atrial flutter (paroxysmal, permanent or persistent) or thrombophilia

          8. Patient on VKA or new oral anticoagulants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Vladimir B Starodubtsev</last_name>
    <phone>+79137262163</phone>
    <email>v_starodubtsev@meshalkin.ru</email>
  </overall_contact>
  <location>
    <facility>
      <name>Andrey A. Karpenko</name>
      <address>
        <city>Novosibirsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Arkhipova</last_name>
      <phone>+79137759326</phone>
      <email>starodub@mail.ru</email>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2017</study_first_submitted>
  <study_first_submitted_qc>March 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2018</study_first_posted>
  <last_update_submitted>March 28, 2018</last_update_submitted>
  <last_update_submitted_qc>March 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Carotid Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

